Wolverine Trading’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,260
| Closed | -$32.3K | – | 4504 |
|
|
2024
Q1 | $32.3K | Sell |
1,260
-1,080
| -46% | -$27.7K | ﹤0.01% | 4287 |
|
|
2023
Q4 | $64.6K | Buy |
2,340
+1,195
| +104% | +$72.9K | ﹤0.01% | 4200 |
|
|
2023
Q3 | $69.6K | Buy |
1,145
+280
| +32% | +$19.7K | ﹤0.01% | 4101 |
|
|
2023
Q2 | $55.7K | Sell |
865
-305
| -26% | -$22.3K | ﹤0.01% | 3916 |
|
|
2023
Q1 | $73K | Sell |
1,170
-335
| -22% | -$38.3K | ﹤0.01% | 3741 |
|
|
2022
Q4 | $208K | Sell |
1,505
-230
| -13% | -$32.4K | ﹤0.01% | 3102 |
|
|
2022
Q3 | $198K | Buy |
+1,735
| New | +$196K | ﹤0.01% | 3628 |
|
|
2022
Q2 | – | Sell |
-1,910
| Closed | -$188K | – | 4533 |
|
|
2022
Q1 | $188K | Buy |
+1,910
| New | +$252K | ﹤0.01% | 4465 |
|
|
2021
Q4 | – | Sell |
-1,405
| Closed | -$345K | – | 5906 |
|
|
2021
Q3 | $345K | Sell |
1,405
-880
| -39% | -$252K | ﹤0.01% | 4483 |
|
|
2021
Q2 | $890K | Sell |
2,285
-1,436
| -39% | -$569K | ﹤0.01% | 2922 |
|
|
2021
Q1 | $1.38M | Buy |
3,721
+2,347
| +171% | +$1.16M | ﹤0.01% | 2339 |
|
|
2020
Q4 | $785K | Sell |
1,374
-479
| -26% | -$304K | ﹤0.01% | 2645 |
|
|
2020
Q3 | $1.32M | Sell |
1,853
-602
| -25% | -$469K | ﹤0.01% | 1810 |
|
|
2020
Q2 | $1.91M | Buy |
2,455
+378
| +18% | +$285K | 0.01% | 1445 |
|
|
2020
Q1 | $1.26M | Sell |
2,077
-509
| -20% | -$496K | ﹤0.01% | 1719 |
|
|
2019
Q4 | $2.93M | Sell |
2,586
-23
| -0.9% | -$25K | 0.01% | 1532 |
|
|
2019
Q3 | $3.14M | Sell |
2,609
-1,205
| -32% | -$1.84M | 0.01% | 1132 |
|
|
2019
Q2 | $6.28M | Buy |
+3,814
| New | +$6.6M | 0.02% | 758 |
|
|
2018
Q4 | – | Sell |
-5,605
| Closed | -$10.6M | – | 4439 |
|
|
2018
Q3 | $10.6M | Buy |
5,605
+2,046
| +57% | +$4.23M | 0.02% | 531 |
|
|
2018
Q2 | $7.87M | Hold |
3,559
| – | – | 0.02% | 614 |
|
|
2018
Q1 | $7.87M | Sell |
3,559
-1,050
| -23% | -$2.67M | 0.02% | 614 |
|
|
2017
Q4 | $10.6M | Buy |
4,609
+2,193
| +91% | +$4.45M | 0.04% | 482 |
|
|
2017
Q3 | $4.3M | Buy |
+2,416
| New | +$3.38M | 0.02% | 862 |
|
|
2017
Q2 | – | Sell |
-733
| Closed | -$871K | – | 4273 |
|
|
2017
Q1 | $871K | Buy |
+733
| New | +$748K | ﹤0.01% | 1835 |
|
|
2016
Q4 | – | Sell |
-386
| Closed | -$332K | – | 4442 |
|
|
2016
Q3 | $332K | Buy |
+386
| New | +$280K | ﹤0.01% | 3090 |
|
Other funds holding BLUE
TCM
CIEC
GLF
EPM
QOP
Wolverine Trading's BLUE Position: Q4 2024 in Review
Wolverine Trading sold out of bluebird bio (BLUE) in Q4 2024, closing a stake of 895 shares — an estimated $7.82K sold.
Wolverine Trading first reported a position in BLUE in Q3 2017 and held it in 22 quarters. The position peaked at $4.51M in Q4 2017. 83 funds tracked by Wall St. Rank hold BLUE as of Q4 2024.
- Wolverine Trading reported no remaining bluebird bio position as of Q4 2024 after selling out during the quarter.
- Wolverine Trading sold 895 bluebird bio shares in Q4 2024, an estimated $7.82K.
- Wolverine Trading first reported a position in bluebird bio in Q3 2017 and held it in 22 quarters.
- Wolverine Trading's bluebird bio position peaked at $4.51M in Q4 2017.
- 83 funds tracked by Wall St. Rank held bluebird bio as of Q4 2024.
Based on Wolverine Trading's 13F filing for Q4 2024, filed 14 Feb 2025.